J.BrantleyThrasherMDFACS

PubMed

• 163 citations
  Erectile function outcome reporting after clinically localized prostate cancer treatment.
  Arthur L. Burnett, Gunnar Aus, Edith D. Canby-Hagino, Michael S. Cookson, Anthony V. D'Amico
  The Journal of Urology. 2007-08-01
• 156 citations
  Best practice statement on cryosurgery for the treatment of localized prostate cancer.
  Richard J. Babaian, Bryan Donnelly, Duke Bahn, John G. Baust, Martin Dineen
  The Journal of Urology. 2008-11-01
• 139 citations
  Small-interfering RNA–induced androgen receptor silencing leads to apoptotic cell death in prostate cancer
  Xinbo Liao, Siqing Tang, J. Brantley Thrasher, Tomas L. Griebling, Benyi Li
  Molecular Cancer Therapeutics. 2005-04-01

Journal Articles

• GSK-3b Controls Autophagy by Modulating LKB1-AMPK Pathway in Prostate Cancer Cells  
  Sun A, Li C, Chen R Huang Y, Chen Q, Cui X, Liu H, Li B, Prostate, 1/6/2015
• Natural compound Alternol induces oxidative stress-dependent apoptotic cell death preferentially in prostate cancer cells  
  Tang Y, Chen R, Huang Y, Li G, Huang Y, Chen J, Duan L, Zhu BT, Zhange X, Li B, Mol Cancer Ther, 1/1/2014
• Modifier 22 on Perioperative Outcomes of Robotic Assisted Laparoscopic Prostatectomy  
  Murray KS, Griffin J, Feng Y, Mirza M, Lopez-Corona E and Duchene DA, Canadian Journal of Urology, 1/1/2014
•  
  Chen R, Zeng X, Zhang R, Huang J, Kuang X, Yang J, Liu J, Tawfik O, Li B, Urol Oncol, 1/1/2014
• Prostate-specific antigen and prostate-specific antigen velocity as threshold indicators in 11C-acetate PET / CTAC scanning for prostate cancer recurrence  
  Dusing RW, Peng W, Lai SM, Grado GL, Holzbeierlein JM, Hill J, Van Veldhuizen PJ, Clin Nucl Med, 1/1/2014
• PI-3 kinase p110b: a therapeutic target in advanced prostate cancers  
  Li, Sun A, Jiang W, Terranova P, Am J Clin Exp Urol 2, 1/1/2014
• Inflammation-Associated Regulation of the Macrophage Inhibitory Cytokine (MIC-1) Gene in Prostate Cancer  
  Dubey S, VanVeldhuizen P, Holzbeierlein J, Tawfik O, Karan D, Oncology Letters, 1/1/2012
• Cancer Immunotherapy: A Paradigm Shift for Prostate Cancer Treatment  
  Karan D, Holzbeierlein J, Van Veldhuizen P, Nature Reviews Urologym, 1/1/2012
• Prostate-targeted biodegradable nanoparticles loaded with androgen receptor silencing constructs eradicate xenograft tumors in mice  
  Yang J, Xie S, Huang Y, Ling M, Liu J, Ran Y, Wang Y, Berklund C, Li B, Nanomedicine, 1/1/2012
• A Phase II Clinical Trial of Neoadjuvant Keotoconazole and Docetaxel Chemotherapy Prior to Radical Prostatectomy in High-Risk Patients  
  Womble P, VanVeldhuizen P, Reed G, Holzbeierlein J, Journal of Urology, 1/24/2011
• A Comparison of Radical Perineal, Radical Retropubic and Robot-assisted Laparoscopic Prostatectomies in a Single-Surgeon Series  
  Mirza M, Art K, Wineland L, Tawfik O, Prostate Cancer, 1/1/2011
• Dual Antigen Target Based Immunotherapy for Prostate Cancer Eliminates the Growth of Established Tumors in Mice  
  Karan D, Dubey S, Van Veldhuizen P, Holzbeierlein J, Tawfik O, Immunotherapy, 1/1/2011
• Targeting the Androgen Receptor-Theory and Practice  
  Dreicer R, Gleave M, Kibel AS, Moul JW, Urology, 1/1/2011
• Adeno-associated Virus-delivered Short Hairpin-structured RNA for Androgen Receptor Gene Silencing Induces Tumor Eradication of Prostate Cancer Xenografts in Nude Mice...  
  Sun A, Tang J, Terranova PF, Zhang X, Int J Cancer, 1/1/2010
• GSK-3&(beta) Promotes Cellular Survival by Modulating Bif-1-Dependent Autophagy and Cell Death  
  Yang J, Takahashi Y, Liu J, Cheng E, Terranova P, Zhao B, Wang H, Li B, Journal of Cell Science, 1/1/2010
• Effect of Dutasteride on the Risk of Prostate Cancer  
  Andriole GL, Bostwick DG, Brawley OW, Gomella LG, Margerber M, Montorsi F, Pettaway CA, Tammela TL, Teloken C, Tindall DJ, Somerville MC, Wilson TH, Fowler IL, Rittsma..., NEJM, 1/1/2010
• Safety and Peri-Operatvie Outcomes During Learning Curve of Robot-Assisted Laparoscopic Prostatectomy (RALP): A Multi-Institutional Study of Fellowship Trained Robot S...  
  Leroy TJ, Thiel DD, Duchene DA, Parker AS, Igel TC, Wehle MJ, Goetzl M, Journal of Endourology, 1/1/2010
• Suppression of Glycogen Synthase Kinase 3 Activity Reduces Prostate Tumor Growth in vivo; a Preclinical Study  
  Zhu Q, Yang J, Han S, Liu J, Holzbeierlein J, Li B, Prostate, 1/1/2010
• Active Surveillance for Prostate Cancer in Veteran Population  
  Lee EK, Baack J, Penn H, Bromfield CT, Duchene DA, Holzbeierlein JM, Can J Urol, 1/1/2010
• Macrophonage Inhibitory Cytokine-1: Possible Bridge Molecule of Inflammation and Prostate Cancer  
  Karan D, Holzbeierlein J, Cancer Research, 1/1/2009
• Effects of Short-Term Finasteride on Apoptopic Factors and Androgen Receptors in Prostate Cancer Cells  
  Bass R, Perry B, Langenstroer P, Dennis KL, Tawfik O, Holzbeierlein J, Journal of Urology, 1/1/2009
• Predictors of Positive Surgical Margins after Radical Perineal Prostatectomy  
  Goetzl MA, Krebill R, Griebling TL, Canadian Journal of Urology, 1/1/2009
• Thoracic Spinal Cord Compression Secondary to Metastatic Synovial Carcinoma: Case Report  
  Arnold P, Clark M, Columna, 1/1/2009
• Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer  
  Smith MR, Egerdie B, Hernandez Toriz N, Feldman, R, Prostate Cancer Study Group, NEJM, 1/1/2009
• Digital Fecal Occult Blood Testing in the Ambulatory Urology Clinic  
  Goetzl MA, Outman JE, Griebling TL, Holzbeierlien JM, Weigel JW, J Am College Surgeons, 1/1/2008
• Join now to see all

Books/Book Chapters

• Conn’s Current Therapy 
  Chapter: Hematuria 
  Page 25 - 27Moben M and Thrasher JBEditors: ET Bope and RD Kellerman.Elsevier, Inc., Philadelphia2015
• The 5-Minute Urology Consult 
  Chapter: Renal Capsular Neoplasms 
  Page 338 - 339Goetzl M, Thrasher, JBEditors: L.G. Gomella.Lippincott Williams & Wilkins, Philadelphia2009
• The 5-Minute Urology Consult 
  Chapter: Hot Flushes (Vasomotor Instability) 
  Page 160 - 161Goetzl M, Thrasher, JBEditors: L.G. Gomella.Lippincott Williams & Wilkins, Philadelphia2009
• The 5-Minute Urology Consult 
  Chapter: Squamous Cell Carcinoma of the Scrotum 
  Page 400 - 401Davis J, Thrasher JBEditors: L.G. Gomella.Lippincott Williams & Wilkins, Philadelphia2009
• The 5-Minute Urology Consult 
  Chapter: Scrotal and Testicular Trauma 
  Page 389 - 399Womble P, Thrasher JBEditors: L.G. Gomella.Lippincott Williams & Wilkins, Philadelphia2009
• Nanotechnology 
  Chapter: Chapter 8: Nano-scaled Techniques in Prostate Cancer Management: From Basic Research to Clinic Settings 
  Page 121 - 132Li B and Thrasher JBAmerican Scientific Publishers, Stevenson Ranch, CA2007
• Comprehensive Textbook of Genitourinary Oncology 
  Chapter: Chapter 16A: Advanced Prostate Cancer – Initial Management of Metastatic Prostatic Cancer 
  Page 315 - 329Maroni PD, Crawford EDEditors: N.J. Vogelzang, P.T. Scardino, W.U. Shipley, F.M.J. Debruyne and WM Linehan.Lippincott Williams & Wilkins, Philadelphia2006
• Complications of Perineal Prostatectomy: Complications of Urologic Surgery 
  Holbeierlein JM and Thrasher JBEditors: Taaneja, Smith, Ehrlich.ElsevierEdition 3rd,2005
• Urological Cancers 
  Chapter: Chapter 16: Molecular Biology of Kidney Cancer 
  Page 169 - 183Holzbeierlein JM and Thrasher JBEditors: J. Waxman.Springer-Verlag2005
• Recent Research Developments in Cancer 
  Chapter: Chapter 7: Androgen Receptor and Cellular Survival in Prostate Cancer 
  Page 65 - 89Li B and Thrasher JBTransworld Research Network, Kerala, India2005
• Comprehensive Textbook of Genitourinary Oncology 
  Chapter: Chapter 16B: Initial Management of Metastatic Prostate Cancer 
  Maroni PD, Crawford DEEditors: N.J. Vogelzang, P.T. Scardino and W.U. Shipley.Williams and Wilkins, BaltimoreEdition 3rd,2004
• The Prostate Cancer Treatment Book - Advice from Leading Prostate Experts at the Nation’s Top Medical Institutions, Seattle Prostate Institute 
  Chapter: Part II Treatment Options, Chapter 6: Should I Have My Prostate Removed? 
  Davis BJ, Mulhall J, Roach M, SylvesterEditors: P. Grimm, J. Blasko and J. Sylvester.McGraw Hill2003
• The Prostate Cancer Treatment Book – Advice from Leading Prostate Experts at the Nation’s Top Medical Institutions, Seattle Prostate Institute 
  Chapter: Part II Treatment Options, Chapter 5: Is Watchful Waiting the Same as Doing Nothing? 
  Davis BJ, Blasko JEditors: P. Grimm, J. Blasko and J. Sylvester.McGraw Hill2003
• The Prostate Cancer Treatment Book – Advice from Leading Prostate Experts at the Nation’s Top Medical Institutions, Seattle Prostate Institute 
  Chapter: Part 1 The Foundation, Chapter 1: What Good is a Prostate, Anyway? 
  Thompson I, Moyad AM and Sylvester JEEditors: P. Grimm, J. Blasko and J. Sylvester.McGraw Hill2003
• Current Clinical Urology 
  Chapter: Semi-rigid, Malleable and Mechanical Penile Prostheses: Survey and State of the Art 
  Brandell RA and Thrasher JBEditors: C.C. Carson.Humana Press, Totowa, NJ2002
• Textbook of Minimally Invasive Urology 
  Chapter: Chapter 41: Radical Perineal Prostatectomy for the Treatment of Localized Prostate Cancer 
  Porter, HJ and Thrasher JBEditors: R.G. Moore, J. Bishoff, S. Docimo and S. Loening.Martin-Dunitz of London, England2002
• Treatment Options in Urological Cancer 
  Chapter: Molecular Biology of Kidney Cancer 
  Page 3 - 31Castle EP, Hallman GSEditors: J. Waxman.Blackwell Science2001
• The 5-Minute Urology Consult 
  Chapter: Inflammatory Bowel Disease-Urologic Considerations 
  Page 316 - 317Lance RS and Thrasher JBEditors: L.G. Gomella.Lippincott Williams & Wilkins, Philadelphia2000
• The 5-Minute Urology Consult 
  Chapter: Urinary Retention – Acute and Chronic 
  Page 174 - 175McMann LP and Thrasher JBEditors: L.G. Gomella.Lippincott Williams & Wilkins, Philadelphia2000
• The 5-Minute Urology Consult 
  Chapter: Granuloma Inguinale 
  Page 298 - 299Joyner BD and Thrasher JBEditors: L.G. Gomella.Lippincott Williams & Wilkins, Philadelphia2000
• The 5-Minute Urology Consult 
  Chapter: Proteinuria 
  Page 112 - 113Lance RS and Thrasher JBEditors: L.G. Gomella.Lippincott Williams & Wilkins, Philadelphia2000
• The 5-Minute Urology Consult 
  Chapter: Renal Oncocytoma 
  Page 472 - 473Ellsworth JB, Joyner BDEditors: L.G. Gomella.Lippincott Williams & Wilkins, Philadelphia2000
• Comprehensive Textbook of Genitourinary Oncology 
  Chapter: Combined Androgen Blockade: Current Controversies. Intermittent/Early vs Late 
  Page 842 - 854O'Reilly KJ, Crawford EDEditors: N.J. Vogelzang, P.T. Scardino, W.U. Shipley, and D.S. Coffey.Williams and Wilkins, BaltimoreEdition 2nd,2000
• Advanced Therapy of Prostatic Disease 
  Chapter: Should T1c Disease be Treated Differently from T2 Disease? 
  Page 267 - 274O'Reilly KJ and Thrasher JBEditors: M.I. Resnick and I.M. Thompson.B.C. Decker, Inc., Ontario2000
• Prostate Cancer 
  Chapter: Secondary Hormonal Therapy in Prostate Cancer 
  Page 397 - 407DeBruyne FMJ, Akaza H, Fitzpatrick JM, Mahler C, Motta, Thrasher JB, Tunn UW, Varkarakis M, and Van Der Poel HGEditors: G. Murphy, S. Khoury, A. Partin and L. Denis.Health Publication Ltd.Edition 2nd,1999
• Join now to see all

Abstracts/Posters

• Prospective Study for Assessment of Association Between Preoperative Frailty and Postoperative Outcomes In Elderly Patients Undergoing Urologic Surgery
  Thrasher JB, 94th Annual Meeting South Central Section Meeting, American Urological Association, Scottsdale, AZ, 1/29/2015
• Alternol, an Anti-Cancer Compound Disturbs Cellular Energy Homeostasis in Prostate Cancer Cells
  Thrasher JB, 94th Annual Meeting South Central Section Meeting, American Urological Association, Scottsdale, AZ, 1/29/2015
• Biopsy Patterns of Patients with GHPIN or ASAP in the Era of Active Surveillance
  Thrasher JB, 94th Annual Meeting South Central Section Meeting, American Urological Association, Scottsdale, AZ, 1/28/2015
• Promoter-Targeted Double-Strand RNA Duplex Enhances DPYSL3 Gene Expression in Prostate Cancer Cells
  Thrasher JB, 107th Annual Meeting American Urological Association, New Orleans, LA, 1/18/2015
• Biopsy Patterns of Patients with HGPIN or ASAP in the Era of Active Surveillance
  Thrasher JB, 16th Annual Meeting Society of Urologic Oncology Annual Meeting, Washington, DC, 1/2/2015
• Does Initial Presentation Affect Survival for Metastatic Prostate Cancer?
  Thrasher JB, 16th Annual Meeting Society of Urologic Oncology Annual Meeting, Washington, DC, 1/2/2015
• SMYD3 is Responsible for Androgen-Induced H3K4 Methylation in Prostate Cancer Cells
  Thrasher JB, 106th Annual Meeting American Urological Association, Orlando, FL, 1/19/2014
• Applicability of Macrophage Inhibitory Cytokine-1 as a Potential Biomarker for Racial Disparity in Prostate Cancer
  Thrasher JB, 106th Annual Meeting American Urological Association, Orlando, FL, 1/19/2014
• A Novel Natural Compound Alternol Induces Ras-Dependent BAX Activation and Apoptotic Cell Death in Prostate Cancer Cells
  Thrasher JB, 93rd Annual Meeting South Central Section Meeting, American Urological Association, Rancho Mirage, CA, 1/11/2014
• Modifier 22 in Patients Undergoing Robotic Assisted Laparoscopic Radical Prostatectomy at a Tertiary Care Center
  Thrasher JB, 93rd Annual Meeting South Central Section Meeting, American Urological Association, Rancho Mirage, CA, 1/11/2014
• Bladder Cancer Education Among Medical Students
  Thrasher JB, 93rd Annual Meeting South Central Section Meeting, American Urological Association, Rancho Mirage, CA, 1/9/2014
• Robotic Simulation Amongst Medical Students: Predicting Skill and Interest
  Thrasher JB, 93rd Annual Meeting South Central Section Meeting, American Urological Association, Rancho Mirage, CA, 1/9/2014
• Outcomes of Impaired Perioperative Glucose Regulation in a Radical Cystectomy Population
  Thrasher JB, 93rd Annual Meeting South Central Section Meeting, American Urological Association, Rancho Mirage, CA, 1/8/2014
• A Prospective Study of erectile Function and Urinary Symptoms after Transrectal Ultrasound and Prostate Biopsy in Men
  Thrasher JB, 105th Annual Meeting American Urological Association, San Diego, CA, 1/7/2013
• Prostate Cancer-Targeted Delivery of Nanomicelle-loaded with p110beta-Specfic Inhibitor TGX221 Pro-drugs Supresseses Xenograft Tumor Growth
  Thrasher JB, 105th Annual Meeting American Urological Association, San Diego, CA, 1/6/2013
• GSK-3b Controls Autophagic Response by Modulating LKB1-AMPK Pathway in Prostate Cancer Cells
  Thrasher JB, 105th Annual Meeting American Urological Association, San Diego, CA, 1/6/2013
• Long Noncoding RNA-mediated Regulation of BCL-2 Expression in Prostate Cancers
  Thrasher JB, 105th Annual Meeting American Urological Association, San Diego, CA, 1/6/2013
• Calcium Channel Blocker Modulates Androgen Receptor-Mediated Gene Expression and Induces Cytotoxicity in Prostate Cancer Cells
  Thrasher JB, 90th Annual Meeting South Central Section Meeting, American Urological Association, San Antonio, TX, 1/15/2011
• Herniation of Colon Between Abdominal Muscle Layers Presenting as Urinary Retention in Patients with Ileal Neobladder
  Thrasher JB, 90th Annual Meeting South Central Section Meeting, American Urological Association, San Antonio, TX, 1/15/2011
• Vaccination with RAD5 carrying a Fusion Construct of Prostate-Specific Antigens Generates Effector T Cells
  Thrasher JB, 103rd Annual Meeting American Urological Association, Washington, DC, 1/15/2011
• Long-term Outcomes of Urethral Reconstruction: A Single Surgeon / Single Institution Experience
  Thrasher JB, 102nd Annual Meeting American Urological Association, San Francisco, CA, 1/31/2010
• Pathologic Upgrading in Patients Eligible for Active Surveillance in a Veteran Population
  Thrasher JB, 102nd Annual Meeting American Urological Association, San Francisco, CA, 1/1/2010
• A Phase II Study of Neoadjuvant Hormone Therapy and Chemotherapy Prior to Prostatectomy in High-Risk Patients
  Thrasher JB, 101st Annual Meeting American Urological Association, Chicago, IL, 1/29/2009
• G-Protein Alpha-Modulated PI2K P1110Beta Activation is Involved in Androgen Receptor Transactivation in Prostate Cancers
  Thrasher JB, 101st Annual Meeting American Urological Association, Chicago, IL, 1/28/2009
• Pathologic Upgrading in Patients Eligible for Active Surveillance in a Veteran Population
  Thrasher JB, SUO Annual Meeting, Bethesda, MD, 1/3/2009
• Join now to see all

Lectures

• The Characterization of Patients with Metastatic Prostate Cancer in a Contemporary Cohort 
  Scottsdale, AZ - 1/31/2015
• Metastatic Prostate Cancer in the Modern Era of PSA Screening 
  New Orleans, LA - 1/18/2015
• Finances for the Urology Resident 
  University of Wisonsin, Madison, WI - 1/5/2015
• Complementary and Alternative Medicine in Renal, Bladder and Prostate Carcinoma 
  University of Wisonsin, Madison, WI - 1/4/2015
• Prostate Biopsies--What do we need to know? 
  Los Cabos, Baja California Sur, Mexico - 1/8/2014
• High Risk Prostate Cancer: Surgery vs Radiation and Hormonal Therapy 
  Los Cabos, Baja California Sur, Mexico - 1/8/2014
• Applicability of MIC-1 as a Potential Biomarker for Radical Disparity in Prostate Cancer 
  Chicago, IL - 1/21/2013
• The Modifier 22 Effect on Perioperative Outcomes of Robotic-Assisted Laparoscopic Prostatectomy 
  Chicago, IL - 1/21/2013
• Radical Retropubic Prostatectomy versus Robotic Assisted Laparoscopic Prostatectomy in High-Risk Prostate Cancer: Rates of 3-Year Biochemical Recurrence 
  Colorado Springs, CO - 1/26/2012
• A Prospective Study of Erectile Function and Urinary Symptoms after Transrectal Ultrasound in Prostate Biopsy 
  Colorado Springs, CO - 1/26/2012
• Novel Natural Compound Alternol Activates the Apical Apoptosis Pathway in Prostate Cancer Cells 
  Colorado Springs, CO - 1/25/2012
• Chemoprevention for Prostate Cancer 
  UNC Charlotte, Charlotte, NC, 2012; Sea Island, GA, 2012 - 1/17/2012
• Transrectal Ultrasound and Biopsies: Are we Downplaying the Complications? 
  Sea Island, GA - 1/8/2012
• Prostate Cancer: Know your Risk, Understand your Options 
  Overland Park Convention Center, Kansas City, KS - 1/19/2011
• Technical Aspects of Radical Prostatectomy—Open 
  Honolulu, HI - 1/17/2011
• CaP Advanced Disease--Hormone Ablation 
  Honolulu, HI - 1/17/2011
• SG1 Chemoprevention for Prostate Cancer, Is it Recommended? 
  Honolulu, HI - 1/17/2011
• Dual Antigen Target-Based Immunotherapy for Prostate Cancer Eliminates the Growth of Established Tumors in Mice 
  San Antonio, TX - 1/16/2011
• Pharmacokinetic Data for Docetaxel in A Phase II Clinical Trial of Neoadjuvant Ketoconazole and Docetaxel Chemotherapy Prior to Radical Prostatectomy in High Risk Pati... 
  San Antonio, TX - 1/15/2011
• Radical Prostatectomy: Comparison of Open vs Robotic Approach 
  Kansas City, MO - 1/8/2011
• Chemoprevention of Prostate Cancer by Antioxidants, Micronutrients and Hormonal Manipulation 
  Indiana University, Indianapolis, IN - 1/8/2010
• Radical Prostatectomy for Localized Prostate Cancer: A Single-Surgeon Comparison of Three Approaches 
  Indiana University, Indianapolis, IN - 1/8/2010
• Multimodal Approach to High-Risk Prostate Cancer 
  Indiana University, Indianapolis, IN - 1/8/2010
• Surgical Approaches for Localized Prostate Cancer: Tailoring the Approach to the Patient 
  University of Iowa, Iowa City, IA - 1/29/2009
• Contemporary Therapies for High-Risk and Advanced Prostate Cancer 
  Chicago, IL - 1/28/2009
• Join now to see all

Other

• Andropause and the Aging Male 
  Griebling TL and Thrasher JB, International Center for Postgraduate Medical Education
  1/1/2003
• Radical Perineal Prostatectomy 
  Thrasher JB, Topics in Urology Audio Series. AUA Office of Education and Research
  1/1/2003
• Selenium in the Prostate 
  Arnold W and Thrasher JB, Newscripts. Chemical and Engineering News
  1/1/2003
• Complications of Treatment of Advanced Prostate Cancer 
  Robinson JJ and Thrasher JB, International Center for Postgraduate Medical Education
  1/1/2002
• Alternative and Complementary Medicine for the Treatment of Prostate Cancer 
  Robinson JJ and Thrasher JB, Medical Education Collaborative
  1/1/2000
• Prostate Cancer: Causes, Risk Factors and Prevention. In: New Frontiers in the Diagnosis and Treatment of Prostate Disease 
  Thrasher JB, Medical Education Collaborative
  1/1/1999
• Join now to see all